LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

LLY

1,040.97

+2.7%↑

JNJ

231.49

+0.92%↑

ABBV

214.52

+0.83%↑

UNH

382.43

-0.24%↓

AZN

189.76

+1.28%↑

Home・Stock List・DaVita Inc

DaVita Inc

Closed

SectorHealthcare

198.36 0.78

Buy Sell

Overview

Share price change

24h

Current

Min

193.34

Max

199.23

Key metrics
By Trading Economics
Income	-804M 275M
Sales	-204M 3.4B
P/E Sector Avg	19.222 49.701
EPS	2.87
Profit margin	8.052
Employees	78,000
EBITDA	-62M 655M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+7.18% upside

Dividends
By Dow Jones
Next Earnings	4 Aug 2026

Market Stats
By TradingEconomics
Market Cap	2.6B 13B
Previous open	197.58
Previous close	198.36

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

142.36 / 144.275 Support & Resistance

DaVita Inc Chart

Past performance is not a reliable indicator of future results.

Related News

29 Dec 2025, 06:30 UTC

Acquisitions, Mergers, Takeovers

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

Peer Comparison

Price change

DaVita Inc Forecast

Price Target

By TipRanks

7.18% upside

12 Months Forecast

Average 211 USD 7.18%

High 235 USD

Low 194 USD

Based on 5 Wall Street analysts offering 12 month price targets forDaVita Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Based on 5 analysts giving stock ratings to DaVita Inc - Dist in the past 3 months.

Technical Score

By Trading Central

142.36 / 144.275Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.